trial · primary record
MGC030
Urothelial Cancer
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 314 |
| Primary completion | 2029-03 |
| Primary endpoint | Number of participants with adverse events (AEs), serious AEs (SAEs), AEs leading to dose interruption, AEs leading to dose reduction or treatment discontinuation, does limiting toxicities and AEs of special interest. |
| Registry ID | NCT07822399 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:43:22.945Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07822399
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.